Schedule 13G ownership disclosure

WEREWOLF THERAPEUTICS INC

Security class unavailable · CUSIP: 95075A107

Event date: 2023-12-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,034,255
Percent of class
8.3800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-23-005971
Form type
SC 13G
Filer
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK
CIK 1165408
Filed
Dec 21, 2023
Reporting period
Dec 11, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub